Plant-derived extracellular vesicles: a synergetic combination of a drug delivery system and a source of natural bioactive compounds
Iwamuro M, Saito S, Yoshioka M, et al
This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)
The Evidence: Some small human studies have shown modest increases in GLP-1 levels and appetite suppression after capsaicin consumption
Every cycle includes the complete peptide supply, bacteriostatic water, syringes, alcohol swabs, a sharps container, step-by-step instructional videos, a dosing calendar, written protocol guides, provider access during the cycle, and body composition analysis at follow-up visits
This show-stopping move should only be performed if the patient requires additional weight loss or glycemic control and has tolerated the previous dosing steps without any missteps